Val-083 Clinical Trials

Solid Tumor Trials

Solid Tumor Trials

Solid Tumor Trials

A Multi-center Study of VAL-083 in Patients With Recurrent Platinum Resistant Ovarian Cancer

Withdrawn

This is an open label, multi-center, Phase 1/2 clinical trial in subjects with recurrent

A Multi-center Study of VAL-083 in Patients With Recurrent Platinum Resistant Ovarian Cancer (REPROVe): More Information

Enrollment

For more information on enrollment into the current VAL-083 trial, please contact us or visit clinicaltrials.gov for location information.

Contact Us View This Study on ClinicalTrials.gov